PNC Financial Services Group Inc. Sells 2,835 Shares of Waters Corporation $WAT

PNC Financial Services Group Inc. trimmed its position in shares of Waters Corporation (NYSE:WAT) by 12.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,315 shares of the medical instruments supplier’s stock after selling 2,835 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Waters were worth $5,791,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Root Financial Partners LLC bought a new position in shares of Waters during the third quarter valued at about $26,000. Hantz Financial Services Inc. grew its position in Waters by 115.4% in the 3rd quarter. Hantz Financial Services Inc. now owns 112 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 60 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new stake in Waters in the 2nd quarter valued at about $53,000. MUFG Securities EMEA plc bought a new position in shares of Waters during the 2nd quarter worth approximately $61,000. Finally, Versant Capital Management Inc boosted its stake in shares of Waters by 510.3% in the 3rd quarter. Versant Capital Management Inc now owns 177 shares of the medical instruments supplier’s stock worth $53,000 after buying an additional 148 shares during the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on the company. Robert W. Baird set a $363.00 price target on Waters in a research report on Tuesday, February 10th. Morgan Stanley began coverage on Waters in a research report on Monday, December 1st. They issued an “equal weight” rating and a $423.00 price objective on the stock. Bank of America decreased their target price on Waters from $410.00 to $350.00 and set a “neutral” rating for the company in a research report on Tuesday, February 10th. Guggenheim reissued a “buy” rating and issued a $440.00 price target on shares of Waters in a report on Tuesday, February 10th. Finally, Wall Street Zen lowered shares of Waters from a “buy” rating to a “hold” rating in a research report on Sunday, February 8th. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $397.68.

Waters Stock Performance

Shares of WAT opened at $328.68 on Friday. The firm has a market cap of $19.57 billion, a PE ratio of 30.52, a PEG ratio of 2.26 and a beta of 1.18. The stock’s fifty day moving average price is $375.40 and its two-hundred day moving average price is $348.35. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.41 and a quick ratio of 1.01. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $414.15.

Waters (NYSE:WAT) last posted its quarterly earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share for the quarter, topping the consensus estimate of $4.50 by $0.03. Waters had a return on equity of 34.79% and a net margin of 20.30%.The company had revenue of $932.36 million during the quarter, compared to the consensus estimate of $928.17 million. During the same quarter in the prior year, the company earned $4.10 EPS. The firm’s quarterly revenue was up 6.9% compared to the same quarter last year. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. On average, equities research analysts forecast that Waters Corporation will post 12.86 EPS for the current year.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.